Alzamend Neuro(ALZN) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ALZN Alzamend Neuro

Watchlist

1.0100
+0.0317+3.24%

Close Mar 21 16:00 ET

1.0300
+0.0200+1.98%

Pre 07:30 ET

6.66MMarket Cap-0.46P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Alzamend Neuro Shares Are Trading Higher After the Company Announced It Will Initiate a Phase II Clinical Trial of AL001 for Major Depressive Disorder
BenzingaMar 18 15:15 ET
Alzamend Neuro, Inc. Plans Phase II Clinical Study of AL001 in Major Depressive Disorder to Compare Lithium Delivery With Marketed Products
Quiver QuantitativeMar 18 08:12 ET
Express News | Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $20
BenzingaMar 17 07:48 ET
Alzamend Neuro Files to Sell 75.775M Shares of Common Stock for Holders
TipRanksMar 13 16:36 ET
Alzamend Neuro | 10-Q: Q3 2025 Earnings Report
SECMar 10 16:31 ET · Announcements
Maxim Group Maintains Alzamend Neuro(ALZN.US) With Hold Rating
Moomoo NewsFeb 26 16:31 ET · Ratings

Comments

MKMM_12

Mar 20 09:11

$Alzamend Neuro (ALZN.US)$ i just entered yesterday after watching on youtube analyst t BWB & its going up👍

Teddy123

Mar 4 21:18

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

$Alzamend Neuro (ALZN.US)$
Can This New Lithium Formulation Revolutionize Bipolar Disorder Treatment? Alzamend's Phase II Trial Targets 7M+ Patients

Jaguar8

Mar 4 21:10

NEWS

$Alzamend Neuro (ALZN.US)$
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital
Tuesday, 4th March at 8:10 am
ATLANTA, March 04, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (NASDAQ: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorde...

Teddy123

Feb 25 21:11

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

$Alzamend Neuro (ALZN.US)$
Can Alzamend's New Lithium Formulation Eliminate Monitoring Requirements? Phase II Trial Set for 2025

Jaguar8

Feb 25 20:31

NEWS

$Alzamend Neuro (ALZN.US)$
EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025
Benzinga· 1 min ago
Alzamend Neuro(ALZN.US)
On Tuesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced its plans to initiate the first of five phase 2 clinical studies of AL001. The first study, in healthy human subjects, is expected to commence in the second quarter of 2025.
The study follows the development of a novel head coil by Tesla Dynamic Coils BV, a key component of the clinical...

Market Insights

Symbol Mini Chart % Chg

AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS

Halozyme Therapeutics

HALO

+1.31%

Collegium Pharmaceutical

COLL

+0.40%

Unlock the Full List